BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cserti CM, Landaw S, Uhl L. Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura? J Clin Apher 2007;22:21-5. [PMID: 17285617 DOI: 10.1002/jca.20114] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Raval JS, Harm SK, Rollins-raval MA, Kiss JE. Seasonal distribution of severe ADAMTS13 deficient idiopathic thrombotic thrombocytopenic purpura: Seasonal Distribution of Idiopathic TTP. J Clin Apheresis 2014;29:113-9. [DOI: 10.1002/jca.21300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
2 Rizzo C, Rizzo S, Scirè E, Di Bona D, Ingrassia C, Franco G, Bono R, Quintini G, Caruso C. Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange. Blood Transfus 2012;10:521-32. [PMID: 22790258 DOI: 10.2450/2012.0122-11] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Callewaert F, Roodt J, Ulrichts H, Stohr T, van Rensburg WJ, Lamprecht S, Rossenu S, Priem S, Willems W, Holz JB. Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura. Blood 2012;120:3603-10. [PMID: 22948047 DOI: 10.1182/blood-2012-04-420943] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
4 Quinn DK, Quinn J, Conlon PJ, Murphy PT. A case of leptospirosis presenting as TTP. Am J Hematol 2013;88:337. [PMID: 23400850 DOI: 10.1002/ajh.23393] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Park YA, Poisson JL, Mcbee MT, Afenyi-annan A. Seasonal association of thrombotic thrombocytopenic purpura: SEASONAL OCCURRENCE OF TTP. Transfusion 2012;52:1530-4. [DOI: 10.1111/j.1537-2995.2011.03481.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Laghmouchi A, Graça NAG, Voorberg J. Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura. Front Immunol 2021;12:757192. [PMID: 34858410 DOI: 10.3389/fimmu.2021.757192] [Reference Citation Analysis]
7 Hussein EA. Idiopathic TTP in the Middle East: Epidemiology and clinical outcomes in infection associated episodes. Transfus Apher Sci 2020;59:102916. [PMID: 32878734 DOI: 10.1016/j.transci.2020.102916] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mancini I, Ricaño-Ponce I, Pappalardo E, Cairo A, Gorski MM, Casoli G, Ferrari B, Alberti M, Mikovic D, Noris M, Wijmenga C, Peyvandi F; Italian Group of TTP Investigators. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura. J Thromb Haemost 2016;14:2356-67. [PMID: 27762046 DOI: 10.1111/jth.13548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M, Calabrò P. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators Inflamm 2017;2017:5620314. [PMID: 28634421 DOI: 10.1155/2017/5620314] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 16.6] [Reference Citation Analysis]
10 Akyol O, Akyol S, Chen CH. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders. Clin Chim Acta 2016;463:109-18. [PMID: 27746209 DOI: 10.1016/j.cca.2016.10.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
11 Boteju M, Weeratunga P, Sivashangar A, Chang T. Cytomegalovirus induced refractory TTP in an immunocompetent individual: a case report. BMC Infect Dis 2019;19:394. [PMID: 31068128 DOI: 10.1186/s12879-019-4037-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010;115:1500-1511; quiz 1662. [PMID: 20032506 DOI: 10.1182/blood-2009-09-243790] [Cited by in Crossref: 330] [Cited by in F6Publishing: 292] [Article Influence: 25.4] [Reference Citation Analysis]
13 Feys HB, Roodt J, Vandeputte N, Pareyn I, Lamprecht S, van Rensburg WJ, Anderson PJ, Budde U, Louw VJ, Badenhorst PN, Deckmyn H, Vanhoorelbeke K. Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). Blood 2010;116:2005-10. [DOI: 10.1182/blood-2010-04-280479] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
14 George JN, Terrell DR, Swisher KK, Vesely SK. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008;23:129-137. [PMID: 18618590 DOI: 10.1002/jca.20169] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
15 Schwameis M, Schörgenhofer C, Assinger A, Steiner MM, Jilma B. VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP. Thromb Haemost 2015;113:708-18. [PMID: 25503977 DOI: 10.1160/TH14-09-0731] [Cited by in Crossref: 75] [Cited by in F6Publishing: 39] [Article Influence: 9.4] [Reference Citation Analysis]
16 Park YA, Schultz EF, Hay SN, Brecher ME. Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection? Am J Clin Pathol 2011;135:85-8. [PMID: 21173128 DOI: 10.1309/AJCPGM0SC6KOTCAN] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
17 van den Born BH, van der Hoeven NV, Groot E, Lenting PJ, Meijers JC, Levi M, van Montfrans GA. Association Between Thrombotic Microangiopathy and Reduced ADAMTS13 Activity in Malignant Hypertension. Hypertension 2008;51:862-6. [DOI: 10.1161/hypertensionaha.107.103127] [Cited by in Crossref: 57] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
18 Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 2011;86:743-51. [PMID: 21850657 DOI: 10.1002/ajh.22091] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
19 Ardalan M, Rezaeifar P. Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy: first report from iran. Nephrourol Mon 2014;6:e18900. [PMID: 25738110 DOI: 10.5812/numonthly.18900] [Reference Citation Analysis]
20 Venkata C, Kashyap R, Farmer JC, Afessa B. Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. J Intensive Care 2013;1:9. [PMID: 25810916 DOI: 10.1186/2052-0492-1-9] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 11.2] [Reference Citation Analysis]
21 Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center. High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center. Transfusion 2014;54:389-97. [PMID: 23711330 DOI: 10.1111/trf.12263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
22 Kessler CS, Khan BA, Lai-miller K. Thrombotic Thrombocytopenic Purpura: A Hematological Emergency. The Journal of Emergency Medicine 2012;43:538-44. [DOI: 10.1016/j.jemermed.2012.01.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
23 Gui RY, Huang QS, Cai X, Wu J, Liu HX, Liu Y, Yang LH, Zhang JY, Cheng YF, Jiang M, Mao M, Fang MY, Liu H, Wang LR, Wang Z, Zhou HB, Lan H, Jiang ZX, Shen XL, Zhang L, Fan SJ, Li Y, Wang QF, Huang XJ, Zhang XH. Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data. Br J Haematol 2020;191:269-81. [PMID: 32452543 DOI: 10.1111/bjh.16767] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. La Presse Médicale 2012;41:e177-88. [DOI: 10.1016/j.lpm.2011.10.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
25 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2503-12. [PMID: 32914535 DOI: 10.1111/jth.15009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
26 van Bolhuis H, Wolters M, de Boer M, Fijnheer R, van Zijll Langhout M, Niphuis H, Eckmann C. Thrombotic thrombocytopenic purpura related to ADAMTS13 deficiency, and successful treatment in a chimpanzee (Pan troglodytes verus). J Med Primatol 2017;46:267-70. [PMID: 28547839 DOI: 10.1111/jmp.12278] [Reference Citation Analysis]
27 Kamal A, Hafez Youssef A, Refaat Mansour A. Acute Hepatitis Caused by Genotype 4 HCV Presenting with Microangiopathic Hemolytic Anemia. ACG Case Rep J 2018;5:e73. [PMID: 30370312 DOI: 10.14309/crj.2018.73] [Reference Citation Analysis]
28 George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989–2007). Kidney International 2009;75:S8-S10. [DOI: 10.1038/ki.2008.609] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]